Clinical Trials Directory

Trials / Completed

CompletedNCT01443013

Analysis of Foxp3 and Vimentin Expression in Renal Transplant Recipient

Predictive Value Analysis of Messenger Ribonucleic Acid (mRNA) Urinary Expression of Foxp3 and Vimentin on Graft Outcome in Renal Transplant Recipient: National Prospective Study

Status
Completed
Phase
Study type
Observational
Enrollment
266 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This observational study is designed to analyse the urinary mRNA expression of Foxp3 and Vimentin, two genes involved in tolerance and early graft dysfunction in 500 renal transplant recipients from 17 renal transplant site in France and to determine the predictive value of these gene expression on the one year graft outcome including graft function, one-year graft histological analysis and incidence of acute rejection.

Detailed description

This observational study is designed to analyse the urinary mRNA expression of Foxp3 and Vimentin, two genes involved in tolerance and early graft dysfunction in 500 renal transplant recipients from 17 renal transplant site in France and to determine the predictive value of these gene expression on the one year graft outcome including graft function,

Conditions

Interventions

TypeNameDescription
OTHERRenal Transplanturinary sample at month 3, 6 and 12

Timeline

Start date
2010-09-01
Primary completion
2014-12-01
Completion
2015-01-01
First posted
2011-09-29
Last updated
2015-10-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01443013. Inclusion in this directory is not an endorsement.